IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 78 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 3.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $228,000 | -28.3% | 172,570 | 0.0% | 0.03% | -28.6% |
| Q1 2018 | $318,000 | -12.9% | 172,570 | 0.0% | 0.04% | -12.5% |
| Q4 2017 | $365,000 | -7.8% | 172,570 | -2.8% | 0.05% | -12.7% |
| Q3 2017 | $396,000 | +29.4% | 177,570 | 0.0% | 0.06% | +19.6% |
| Q2 2017 | $306,000 | -30.3% | 177,570 | 0.0% | 0.05% | -28.1% |
| Q1 2017 | $439,000 | +60.2% | 177,570 | -2.7% | 0.06% | +56.1% |
| Q4 2016 | $274,000 | -39.8% | 182,570 | +2.8% | 0.04% | -37.9% |
| Q3 2016 | $455,000 | +67.3% | 177,570 | 0.0% | 0.07% | +57.1% |
| Q2 2016 | $272,000 | -22.7% | 177,570 | 0.0% | 0.04% | -30.0% |
| Q1 2016 | $352,000 | -35.9% | 177,570 | 0.0% | 0.06% | -38.1% |
| Q4 2015 | $549,000 | -7.7% | 177,570 | 0.0% | 0.10% | -5.8% |
| Q3 2015 | $595,000 | -9.7% | 177,570 | 0.0% | 0.10% | +8.4% |
| Q2 2015 | $659,000 | 0.0% | 177,570 | 0.0% | 0.10% | +9.2% |
| Q1 2015 | $659,000 | +22.5% | 177,570 | +45.5% | 0.09% | +22.5% |
| Q4 2014 | $538,000 | +92.8% | 122,000 | 0.0% | 0.07% | +86.8% |
| Q3 2014 | $279,000 | -21.2% | 122,000 | 0.0% | 0.04% | -19.1% |
| Q2 2014 | $354,000 | -39.0% | 122,000 | -14.1% | 0.05% | -45.3% |
| Q1 2014 | $580,000 | -5.1% | 142,000 | +7.6% | 0.09% | -14.0% |
| Q4 2013 | $611,000 | – | 132,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|